Cerebellar Stimulation and Cognitive Control

  • STATUS
    Recruiting
  • days left to enroll
    8
  • participants needed
    200
  • sponsor
    Krystal Parker, PhD
Updated on 26 January 2021
depression
bipolar disorder
depressed mood
transcranial magnetic stimulation
cognitive deficits
schizophrenia
major depressive disorder
autism

Summary

The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder, Parkinson's disease, and major depression.

Description

Our recent work found that patients with Parkinson's disease and schizophrenia have impaired frontal EEG rhythms in the theta and delta range (1-8 Hz).We have been using transcranial direct current stimulation to recover these rhythms as patients perform elementary cognitive tasks. We found that although we are able to modulate cerebellar and frontal activity with tDCS, this effect is minimal as the depth of the current is not great enough to modulate all cerebellar activity. Here we use transcranial magnetic stimulation (TMS) to modulate neural activity in the frontal cortex and recover cognitive function in patients with autism, schizophrenia, bipolar disorder and Parkinson's disease.

The purpose of the study is to explore cerebellar stimulation as a potential new treatment to restore frontal activity and cognitive function in autism, schizophrenia, bipolar disorder and Parkinson's disease.Subjects will be brought in for 5 to 6 separate visits, with cerebellar or sham TMS stimulation twice per day for 5 days, as well as 3 follow-up visits.During these visits the patient will have cognitive, disease-specific and emotional testing, including EEG testing and MRI imaging. For those participants that received sham stimulation we will again use EEG to record how single pulses of magnetic or electrical stimulation influences other regions of the cerebellum and downstream brain regions. These data will provide insight into how the cerebellum may influence downstream brain regions and play a role in cognitive and motor performance. All data will be analyzed offline to determine if performance on the interval timing task and/or frontal brain rhythms change following transcranial magnetic stimulation as compared to the pre-stimulation blocks of trials. Additionally, we will analyze changes in their cognitive function, symptom ratings, functional and structural MRI, and mood following stimulation. Controls will receive both active and sham treatment for comparison.

Details
Condition Pervasive developmental disorder, Endogenous depression, Depression, Bipolar Disorder, Schizophrenia, Parkinson's disease, Depression (Major/Severe), Depression (Adolescent), Depression (Pediatric), Depression (Adult and Geriatric), Depression (Treatment-Resistant), Schizophrenia and Schizoaffective Disorders, Depressed, Bipolar Disorders (Pediatric), Schizophrenia and Schizoaffective Disorders (Pediatric), Autism Spectrum Disorder (ASD), Manic Disorders, Autism Spectrum Disorder, autism spectrum disorders, depressive disorder, schizophrenia disorders, parkinson's, parkinson disease, depressed mood, miserable, depressive disorders
Treatment Repetitive Transcranial Magnetic Stimulation (rTMS), Sham Repetitive Transcranial Magnetic Stimulation (rTMS)
Clinical Study IdentifierNCT03217110
SponsorKrystal Parker, PhD
Last Modified on26 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

A clinical diagnosis consistent with enrollment

Exclusion Criteria

History of recurrent seizures or epilepsy
Any other neurological or psychiatric diagnosis outside the diagnosis for which the participant is enrolled
Active substance use disorder in the past 6 months other than tobacco use disorder
Inability to consent for study
Pacemaker
Coronary Stent
Defibrillator
Neurostimulation
Claustrophobia
Uncontrolled high blood pressure
Atrial fibrillation
Significant heart disease
Hemodynamic instability
Kidney disease
Pregnant, trying to become pregnant, or breast feeding
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note